HEALTHCARE | Staff Reporter, Korea

South Korea pharma firms' sales surge in 2020

Several local pharmas hit over a trillion won during the year.

South Korea’s major drug and biopharmaceutical companies saw their sales surge in 2020, with 11 local pharma firms registering sales of over $910m (KRW1t) during the year, Yonhap reported.

For instance, contract manufacturing organization giant Samsung Biologics, the biopharmaceutical arm of top conglomerate Samsung Group, posted sales of more than $910m (KRW1t) for the first time since its inception in 2011.

Celltrion and affiliate Celltrion Healthcare remained in the trillion-won club last year, with their sales for the first three quarters alone surpassing the milestone.

Meanwhile, Chong Kun Dang saw its sales jump 21%, with the top line of Green Cross climbing nearly 11%.

Do you know more about this story? Contact us anonymously through this link.

Click here to learn about advertising, content sponsorship, events & rountables, custom media solutions, whitepaper writing, sales leads or eDM opportunities with us.

To get a media kit and information on advertising or sponsoring click here.